is reta a glp 1 retatrutide trial clinical data & dosing — must read (Reta) isn't just another Reta (RUO) | GIP/GLP-1/GCG Agonist

NEWS Correction 30 June 2025 Obesity drugs made in China could power next wave of treatments Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription $32.99 / 30 days cancel any time Subscribe to this journal Receive 52 print issues and online access $199.00 per year only $3.83 per issue Rent or buy this article Prices vary by article type from$1.95 to$39.95 Prices may be subject to local taxes which are calculated during checkout Nature 643 , 315-316 (2025) doi: Updates & Corrections Correction 30 June 2025 : An earlier version of this story misnamed the US Food and Drug Administration

Nelson LW, et al

Description of adverse reactions that occur with standard use of drugs and measures that should be taken in this case Rare cases of skin rash have been reported following intramuscular administration and disappear after discontinuation of treatment

The success of such an undertaking depends, however, on a few particular, both practical and theoretical, considerations

however, no maternal or fetal complications have been associated with doses that are recommended during pregnancy, and appropriate treatment should not be withheld from pregnant women with vitamin B12 responsive anemias